Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12609000566235Phase 3Completed
Phase 3, randomised, double-blind trial in gingivostomatitis, pharyngitis and herpangina comparing 2% viscous lignocaine with Placebo (2 arms). Primary endpoint: Amount of fluid ingested. Started Nov 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12609000566235.